Klug GM - Search Results

1

Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 update.

Klug GM, Boyd A, McGlade A, Stehmann C, Masters CL, Collins SJ. Klug GM, et al. Commun Dis Intell Q Rep. 2010 Jun;34(2):96-101. Commun Dis Intell Q Rep. 2010. PMID: 20677418 Free article.

2

The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons.

Caswell MD, Mok SS, Henry A, Cappai R, Klug G, Beyreuther K, Masters CL, Small DH. Caswell MD, et al. Eur J Biochem. 1999 Dec;266(2):509-16. doi: 10.1046/j.1432-1327.1999.00886.x. Eur J Biochem. 1999. PMID: 10561592 Free article.

3

Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia.

Brooke FJ, Boyd A, Klug GM, Masters CL, Collins SJ. Brooke FJ, et al. Among authors: klug gm. Med J Aust. 2004 Feb 16;180(4):177-81. doi: 10.5694/j.1326-5377.2004.tb05863.x. Med J Aust. 2004. PMID: 14960140

4

Creutzfeldt-Jakob disease surveillance in Australia January 1970 to December 2003.

Klug GM, Lewis V, Boyd A, Lee JS, Masters CL, Collins SJ. Klug GM, et al. Commun Dis Intell Q Rep. 2004;28(3):356-8. Commun Dis Intell Q Rep. 2004. PMID: 15574060 Free article.

5

Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I. Ladogana A, et al. Among authors: klug gm. Neurology. 2005 May 10;64(9):1586-91. doi: 10.1212/01.WNL.0000160117.56690.B2. Neurology. 2005. PMID: 15883321

6

Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.

Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Lewis V, et al. Among authors: klug gm. Neurology. 2005 Jul 12;65(1):113-8. doi: 10.1212/01.wnl.0000167188.65787.a0. Neurology. 2005. PMID: 16009895

7

Creutzfeldt-Jakob disease: Australian surveillance update to 31 December 2004.

Klug GM, Boyd A, Lewis V, Kvasnicka M, Lee JS, Masters CL, Collins SJ. Klug GM, et al. Commun Dis Intell Q Rep. 2005;29(3):269-71. Commun Dis Intell Q Rep. 2005. PMID: 16220862 Free article. Review.

8

Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.

Collins SJ, Lewis V, Brazier MW, Hill AF, Lawson VA, Klug GM, Masters CL. Collins SJ, et al. Among authors: klug gm. Neurobiol Dis. 2005 Nov;20(2):336-46. doi: 10.1016/j.nbd.2005.03.014. Neurobiol Dis. 2005. PMID: 16242640

9

Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S. Brazier MW, et al. Among authors: klug gm. Brain Res Bull. 2006 Jan 30;68(5):346-54. doi: 10.1016/j.brainresbull.2005.09.010. Epub 2005 Oct 5. Brain Res Bull. 2006. PMID: 16377442

10

Creutzfeldt-Jakob disease: Australian surveillance update to December 2005.

Klug GM, Boyd A, Lewis V, Douglass SL, Argent R, Lee JS, Masters CL, Collins SJ; Australian National Creutzfeldt-Jakob Disease Registry. Klug GM, et al. Commun Dis Intell Q Rep. 2006;30(1):144-7. Commun Dis Intell Q Rep. 2006. PMID: 16637244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters